Most Read Articles
16 May 2019
Empagliflozin treatment in patients with type 2 diabetes mellitus exerts beneficial effects on cardiovascular (CV) risk factors, including blood pressure and uric acid, according to a systematic review and meta-analysis.
Pearl Toh, 17 May 2019
Metformin continues to protect high-risk individuals from developing type 2 diabetes (T2D) over 15 years, especially among those with higher glycaemic status at baseline and women reporting a history of gestational diabetes mellitus (GDM), according to long-term results from DPP/DPPOS*.
16 May 2019
Due to the increasing global prevalence of obesity, older adults may live more years of their remaining life with limited physical function and activities in daily living (ADLs), according to a study, adding that older adults, their families and healthcare systems should be aware of this problem.
Jairia Dela Cruz, 4 days ago
One anastomosis gastric bypass is as effective as the standard Roux-en-Y procedure in terms of weight loss and metabolic improvements 24 months after the surgery, according to the results of the open-label YOMEGA trial.

Insulinaemic potential of diet linked to colorectal cancer risk

13 Sep 2018

A recent study suggests that the influence of dietary intake on the development of colorectal cancer is partly caused by dietary insulinaemic potential.

Associations between hyperinsulinaemic diets and colorectal cancer risk were assessed using an empirical dietary index for hyperinsulinaemia (EDIH), a food-based index that characterizes dietary insulinaemic potential based on circulating C-peptide concentrations.

Using food-frequency questionnaires, the investigators evaluated diet in 46,210 men (Health Professionals Follow-Up Study, 1986–2012) and 74,191 women (Nurses’ Health Study, 1984–2012) to calculate EDIH scores.

A total of 2,683 incident colorectal cancer cases were identified over 26 years of follow-up. Comparing participants in the highest vs those in the lower quintiles, higher EDIH scores in men, women, and both men and women were associated with 33 percent (hazard ratio [HR], 1.33; 95 percent CI, 1.11–1.61; p=0.0005), 22 percent (HR, 1.22; 1.03–1.45; p=0.01) and 26 percent (pooled HR, 1.26; 1.2–1.42; p<0.0001) higher risk of developing colorectal cancer, respectively.

While such associations were limited to the distal colon and rectum in men and to the distal and proximal colon in women, combined risk estimates remained significant for all anatomic locations except for the rectum.

Comparing participants in extreme EDIH quintiles, no significant association was observed for proximal colon cancer in men (HR, 1.15; 0.84–1.57; p=0.32). However, there was an increased risk for distal colon (HR, 1.63; 1.14–2.32; p=0.002) and rectal (HR, 1.63; 1.09–2.44; p=0.01) cancer. The risk in women was heightened for proximal (HR, 1.28; 1.00–1.63; p=0.03) and distal (HR, 1.46; 1.05–2.03; p=0.03) colon cancer but not for rectal cancer (HR, 0.88; 0.60–1.29; p=0.61).

“Insulin response may be important in colorectal cancer development. Diet modulates insulin response and may be a modifiable factor in colorectal cancer prevention,” the investigators noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
16 May 2019
Empagliflozin treatment in patients with type 2 diabetes mellitus exerts beneficial effects on cardiovascular (CV) risk factors, including blood pressure and uric acid, according to a systematic review and meta-analysis.
Pearl Toh, 17 May 2019
Metformin continues to protect high-risk individuals from developing type 2 diabetes (T2D) over 15 years, especially among those with higher glycaemic status at baseline and women reporting a history of gestational diabetes mellitus (GDM), according to long-term results from DPP/DPPOS*.
16 May 2019
Due to the increasing global prevalence of obesity, older adults may live more years of their remaining life with limited physical function and activities in daily living (ADLs), according to a study, adding that older adults, their families and healthcare systems should be aware of this problem.
Jairia Dela Cruz, 4 days ago
One anastomosis gastric bypass is as effective as the standard Roux-en-Y procedure in terms of weight loss and metabolic improvements 24 months after the surgery, according to the results of the open-label YOMEGA trial.